Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Bayer presents new adenosine receptor ligands and potential therapeutic applications

May 23, 2001

Antiarrhythmic agents from Aventis act on Kv1.5 channels

May 23, 2001

Small-molecule sPLA2 inhibitor appears to have beneficial effects in severe sepsis

May 23, 2001

Low-dose tolafentrine may improve efficacy of inhaled prostanoids in chronic PH therapy

May 23, 2001

Antiischemic adenosine agonists designed by Pfizer

May 22, 2001

Promising preliminary results reported for AGI-1067 in postangioplasty restenosis

May 22, 2001

Endovasc's Liprostin bypasses phase I/II and enters phase III for critical limb ischemia

May 21, 2001

Statistically significant reductions in BP reported for enalapril/nitrendipine

May 21, 2001

Selective PDE5 inhibitors reported by Icos along with potential therapeutic uses

May 18, 2001

New antiarrhythmic agents designed by Nissan to have fewer side effects

May 17, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...